Nuveen, LLC Cabaletta Bio, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 434,389 shares of CABA stock, worth $556,017. This represents 0.0% of its overall portfolio holdings.
Number of Shares
434,389Holding current value
$556,017% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
109Shares Held
39.6MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$6.09 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$5.21 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$4.65 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$3.64 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$3.53 Million1.64% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $37.1M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...